Industry Research Reports
Global Glimepiride API Market Research Report 2026
Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 145 Pages
Report ld: 6551275
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Glimepiride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Glimepiride API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
The North American market for Glimepiride API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Glimepiride API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Glimepiride API include Dr. Reddy’s Laboratories Ltd., SANOFI Active Ingredient Solutions, Dishman Carbogen Amcis, Glenmark Pharmaceuticals, Sharon Bio-Medicine Limited, Supra Chemicals, Rakshit Drugs, Estechpharma Co., Ltd., Nishchem International Pvt. Ltd, Nexchem Pharmaceutical Co, ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Glimepiride API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Glimepiride API. The Glimepiride API market size, estimates, and forecasts are provided in terms of output/shipments (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Glimepiride API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Glimepiride API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- SANOFI Active Ingredient Solutions
- Dishman Carbogen Amcis
- Glenmark Pharmaceuticals
- Sharon Bio-Medicine Limited
- Supra Chemicals
- Rakshit Drugs
- Estechpharma Co., Ltd.
- Nishchem International Pvt. Ltd
- Nexchem Pharmaceutical Co, ltd
- Maps Laboratories Private Limited
- CAD Middle East Pharmaceutical
- Hanways Chempharm Co., Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Glimepiride Tablets
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Glimepiride API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Glimepiride API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Glimepiride API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Glimepiride API Market Overview
1.1 Product Definition
1.2 Glimepiride API by Type
1.2.1 Global Glimepiride API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Glimepiride API by Application
1.3.1 Global Glimepiride API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Glimepiride Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Glimepiride API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Glimepiride API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Glimepiride API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Glimepiride API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Glimepiride API Production Market Share by Manufacturers (2021–2026)
2.2 Global Glimepiride API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Glimepiride API, Industry Ranking, 2024 vs 2025
2.4 Global Glimepiride API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Glimepiride API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Glimepiride API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Glimepiride API, Product Offerings and Applications
2.8 Global Key Manufacturers of Glimepiride API, Date of Entry into the Industry
2.9 Glimepiride API Market Competitive Situation and Trends
2.9.1 Glimepiride API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Glimepiride API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Glimepiride API Production by Region
3.1 Global Glimepiride API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Glimepiride API Production Value by Region (2021–2032)
3.2.1 Global Glimepiride API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Glimepiride API by Region (2027–2032)
3.3 Global Glimepiride API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Glimepiride API Production Volume by Region (2021–2032)
3.4.1 Global Glimepiride API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Glimepiride API by Region (2027–2032)
3.5 Global Glimepiride API Market Price Analysis by Region (2021–2032)
3.6 Global Glimepiride API Production, Value, and Year-over-Year Growth
3.6.1 India Glimepiride API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Glimepiride API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Glimepiride API Production Value Estimates and Forecasts (2021–2032)
3.6.4 South Korea Glimepiride API Production Value Estimates and Forecasts (2021–2032)
4 Glimepiride API Consumption by Region
4.1 Global Glimepiride API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Glimepiride API Consumption by Region (2021–2032)
4.2.1 Global Glimepiride API Consumption by Region (2021–2026)
4.2.2 Global Glimepiride API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Glimepiride API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Glimepiride API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Glimepiride API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Glimepiride API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Glimepiride API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Glimepiride API Production by Type (2021–2032)
5.1.1 Global Glimepiride API Production by Type (2021–2026)
5.1.2 Global Glimepiride API Production by Type (2027–2032)
5.1.3 Global Glimepiride API Production Market Share by Type (2021–2032)
5.2 Global Glimepiride API Production Value by Type (2021–2032)
5.2.1 Global Glimepiride API Production Value by Type (2021–2026)
5.2.2 Global Glimepiride API Production Value by Type (2027–2032)
5.2.3 Global Glimepiride API Production Value Market Share by Type (2021–2032)
5.3 Global Glimepiride API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Glimepiride API Production by Application (2021–2032)
6.1.1 Global Glimepiride API Production by Application (2021–2026)
6.1.2 Global Glimepiride API Production by Application (2027–2032)
6.1.3 Global Glimepiride API Production Market Share by Application (2021–2032)
6.2 Global Glimepiride API Production Value by Application (2021–2032)
6.2.1 Global Glimepiride API Production Value by Application (2021–2026)
6.2.2 Global Glimepiride API Production Value by Application (2027–2032)
6.2.3 Global Glimepiride API Production Value Market Share by Application (2021–2032)
6.3 Global Glimepiride API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Glimepiride API Company Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Glimepiride API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 SANOFI Active Ingredient Solutions
7.2.1 SANOFI Active Ingredient Solutions Glimepiride API Company Information
7.2.2 SANOFI Active Ingredient Solutions Glimepiride API Product Portfolio
7.2.3 SANOFI Active Ingredient Solutions Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 SANOFI Active Ingredient Solutions Main Business and Markets Served
7.2.5 SANOFI Active Ingredient Solutions Recent Developments/Updates
7.3 Dishman Carbogen Amcis
7.3.1 Dishman Carbogen Amcis Glimepiride API Company Information
7.3.2 Dishman Carbogen Amcis Glimepiride API Product Portfolio
7.3.3 Dishman Carbogen Amcis Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Dishman Carbogen Amcis Main Business and Markets Served
7.3.5 Dishman Carbogen Amcis Recent Developments/Updates
7.4 Glenmark Pharmaceuticals
7.4.1 Glenmark Pharmaceuticals Glimepiride API Company Information
7.4.2 Glenmark Pharmaceuticals Glimepiride API Product Portfolio
7.4.3 Glenmark Pharmaceuticals Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.5 Sharon Bio-Medicine Limited
7.5.1 Sharon Bio-Medicine Limited Glimepiride API Company Information
7.5.2 Sharon Bio-Medicine Limited Glimepiride API Product Portfolio
7.5.3 Sharon Bio-Medicine Limited Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Sharon Bio-Medicine Limited Main Business and Markets Served
7.5.5 Sharon Bio-Medicine Limited Recent Developments/Updates
7.6 Supra Chemicals
7.6.1 Supra Chemicals Glimepiride API Company Information
7.6.2 Supra Chemicals Glimepiride API Product Portfolio
7.6.3 Supra Chemicals Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Supra Chemicals Main Business and Markets Served
7.6.5 Supra Chemicals Recent Developments/Updates
7.7 Rakshit Drugs
7.7.1 Rakshit Drugs Glimepiride API Company Information
7.7.2 Rakshit Drugs Glimepiride API Product Portfolio
7.7.3 Rakshit Drugs Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Rakshit Drugs Main Business and Markets Served
7.7.5 Rakshit Drugs Recent Developments/Updates
7.8 Estechpharma Co., Ltd.
7.8.1 Estechpharma Co., Ltd. Glimepiride API Company Information
7.8.2 Estechpharma Co., Ltd. Glimepiride API Product Portfolio
7.8.3 Estechpharma Co., Ltd. Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Estechpharma Co., Ltd. Main Business and Markets Served
7.8.5 Estechpharma Co., Ltd. Recent Developments/Updates
7.9 Nishchem International Pvt. Ltd
7.9.1 Nishchem International Pvt. Ltd Glimepiride API Company Information
7.9.2 Nishchem International Pvt. Ltd Glimepiride API Product Portfolio
7.9.3 Nishchem International Pvt. Ltd Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Nishchem International Pvt. Ltd Main Business and Markets Served
7.9.5 Nishchem International Pvt. Ltd Recent Developments/Updates
7.10 Nexchem Pharmaceutical Co, ltd
7.10.1 Nexchem Pharmaceutical Co, ltd Glimepiride API Company Information
7.10.2 Nexchem Pharmaceutical Co, ltd Glimepiride API Product Portfolio
7.10.3 Nexchem Pharmaceutical Co, ltd Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Nexchem Pharmaceutical Co, ltd Main Business and Markets Served
7.10.5 Nexchem Pharmaceutical Co, ltd Recent Developments/Updates
7.11 Maps Laboratories Private Limited
7.11.1 Maps Laboratories Private Limited Glimepiride API Company Information
7.11.2 Maps Laboratories Private Limited Glimepiride API Product Portfolio
7.11.3 Maps Laboratories Private Limited Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Maps Laboratories Private Limited Main Business and Markets Served
7.11.5 Maps Laboratories Private Limited Recent Developments/Updates
7.12 CAD Middle East Pharmaceutical
7.12.1 CAD Middle East Pharmaceutical Glimepiride API Company Information
7.12.2 CAD Middle East Pharmaceutical Glimepiride API Product Portfolio
7.12.3 CAD Middle East Pharmaceutical Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 CAD Middle East Pharmaceutical Main Business and Markets Served
7.12.5 CAD Middle East Pharmaceutical Recent Developments/Updates
7.13 Hanways Chempharm Co., Limited
7.13.1 Hanways Chempharm Co., Limited Glimepiride API Company Information
7.13.2 Hanways Chempharm Co., Limited Glimepiride API Product Portfolio
7.13.3 Hanways Chempharm Co., Limited Glimepiride API Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Hanways Chempharm Co., Limited Main Business and Markets Served
7.13.5 Hanways Chempharm Co., Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Glimepiride API Industry Chain Analysis
8.2 Glimepiride API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Glimepiride API Production Modes and Processes
8.4 Glimepiride API Sales and Marketing
8.4.1 Glimepiride API Sales Channels
8.4.2 Glimepiride API Distributors
8.5 Glimepiride API Customer Analysis
9 Glimepiride API Market Dynamics
9.1 Glimepiride API Industry Trends
9.2 Glimepiride API Market Drivers
9.3 Glimepiride API Market Challenges
9.4 Glimepiride API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Glimepiride API Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Glimepiride API Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Glimepiride API Production Capacity (Ton) by Manufacturers in 2025
Table 4. Global Glimepiride API Production by Manufacturers (Ton), 2021–2026
Table 5. Global Glimepiride API Production Market Share by Manufacturers (2021–2026)
Table 6. Global Glimepiride API Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Glimepiride API Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Glimepiride API, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Glimepiride API Production Value, 2025
Table 10. Global Market Glimepiride API Average Price by Manufacturers (US$/Ton), 2021–2026
Table 11. Global Key Manufacturers of Glimepiride API, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Glimepiride API, Product Offerings and Applications
Table 13. Global Key Manufacturers of Glimepiride API, Date of Entry into the Industry
Table 14. Global Glimepiride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Glimepiride API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Glimepiride API Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Glimepiride API Production Value Market Share by Region (2021–2026)
Table 19. Global Glimepiride API Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Glimepiride API Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Glimepiride API Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)
Table 22. Global Glimepiride API Production (Ton) by Region (2021–2026)
Table 23. Global Glimepiride API Production Market Share by Region (2021–2026)
Table 24. Global Glimepiride API Production (Ton) Forecast by Region (2027–2032)
Table 25. Global Glimepiride API Production Market Share Forecast by Region (2027–2032)
Table 26. Global Glimepiride API Market Average Price (US$/Ton) by Region (2021–2026)
Table 27. Global Glimepiride API Market Average Price (US$/Ton) by Region (2027–2032)
Table 28. Global Glimepiride API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)
Table 29. Global Glimepiride API Consumption by Region (Ton), 2021–2026
Table 30. Global Glimepiride API Consumption Market Share by Region (2021–2026)
Table 31. Global Glimepiride API Forecasted Consumption by Region (Ton), 2027–2032
Table 32. Global Glimepiride API Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 34. North America Glimepiride API Consumption by Country (Ton), 2021–2026
Table 35. North America Glimepiride API Consumption by Country (Ton), 2027–2032
Table 36. Europe Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 37. Europe Glimepiride API Consumption by Country (Ton), 2021–2026
Table 38. Europe Glimepiride API Consumption by Country (Ton), 2027–2032
Table 39. Asia Pacific Glimepiride API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)
Table 40. Asia Pacific Glimepiride API Consumption by Region (Ton), 2021–2026
Table 41. Asia Pacific Glimepiride API Consumption by Region (Ton), 2027–2032
Table 42. Latin America, Middle East & Africa Glimepiride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 43. Latin America, Middle East & Africa Glimepiride API Consumption by Country (Ton), 2021–2026
Table 44. Latin America, Middle East & Africa Glimepiride API Consumption by Country (Ton), 2027–2032
Table 45. Global Glimepiride API Production (Ton) by Type (2021–2026)
Table 46. Global Glimepiride API Production (Ton) by Type (2027–2032)
Table 47. Global Glimepiride API Production Market Share by Type (2021–2026)
Table 48. Global Glimepiride API Production Market Share by Type (2027–2032)
Table 49. Global Glimepiride API Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Glimepiride API Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Glimepiride API Production Value Market Share by Type (2021–2026)
Table 52. Global Glimepiride API Production Value Market Share by Type (2027–2032)
Table 53. Global Glimepiride API Price (US$/Ton) by Type (2021–2026)
Table 54. Global Glimepiride API Price (US$/Ton) by Type (2027–2032)
Table 55. Global Glimepiride API Production (Ton) by Application (2021–2026)
Table 56. Global Glimepiride API Production (Ton) by Application (2027–2032)
Table 57. Global Glimepiride API Production Market Share by Application (2021–2026)
Table 58. Global Glimepiride API Production Market Share by Application (2027–2032)
Table 59. Global Glimepiride API Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Glimepiride API Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Glimepiride API Production Value Market Share by Application (2021–2026)
Table 62. Global Glimepiride API Production Value Market Share by Application (2027–2032)
Table 63. Global Glimepiride API Price (US$/Ton) by Application (2021–2026)
Table 64. Global Glimepiride API Price (US$/Ton) by Application (2027–2032)
Table 65. Dr. Reddy’s Laboratories Ltd. Glimepiride API Company Information
Table 66. Dr. Reddy’s Laboratories Ltd. Glimepiride API Specification and Application
Table 67. Dr. Reddy’s Laboratories Ltd. Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 68. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
Table 69. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
Table 70. SANOFI Active Ingredient Solutions Glimepiride API Company Information
Table 71. SANOFI Active Ingredient Solutions Glimepiride API Specification and Application
Table 72. SANOFI Active Ingredient Solutions Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 73. SANOFI Active Ingredient Solutions Main Business and Markets Served
Table 74. SANOFI Active Ingredient Solutions Recent Developments/Updates
Table 75. Dishman Carbogen Amcis Glimepiride API Company Information
Table 76. Dishman Carbogen Amcis Glimepiride API Specification and Application
Table 77. Dishman Carbogen Amcis Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 78. Dishman Carbogen Amcis Main Business and Markets Served
Table 79. Dishman Carbogen Amcis Recent Developments/Updates
Table 80. Glenmark Pharmaceuticals Glimepiride API Company Information
Table 81. Glenmark Pharmaceuticals Glimepiride API Specification and Application
Table 82. Glenmark Pharmaceuticals Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 83. Glenmark Pharmaceuticals Main Business and Markets Served
Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
Table 85. Sharon Bio-Medicine Limited Glimepiride API Company Information
Table 86. Sharon Bio-Medicine Limited Glimepiride API Specification and Application
Table 87. Sharon Bio-Medicine Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 88. Sharon Bio-Medicine Limited Main Business and Markets Served
Table 89. Sharon Bio-Medicine Limited Recent Developments/Updates
Table 90. Supra Chemicals Glimepiride API Company Information
Table 91. Supra Chemicals Glimepiride API Specification and Application
Table 92. Supra Chemicals Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 93. Supra Chemicals Main Business and Markets Served
Table 94. Supra Chemicals Recent Developments/Updates
Table 95. Rakshit Drugs Glimepiride API Company Information
Table 96. Rakshit Drugs Glimepiride API Specification and Application
Table 97. Rakshit Drugs Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 98. Rakshit Drugs Main Business and Markets Served
Table 99. Rakshit Drugs Recent Developments/Updates
Table 100. Estechpharma Co., Ltd. Glimepiride API Company Information
Table 101. Estechpharma Co., Ltd. Glimepiride API Specification and Application
Table 102. Estechpharma Co., Ltd. Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 103. Estechpharma Co., Ltd. Main Business and Markets Served
Table 104. Estechpharma Co., Ltd. Recent Developments/Updates
Table 105. Nishchem International Pvt. Ltd Glimepiride API Company Information
Table 106. Nishchem International Pvt. Ltd Glimepiride API Specification and Application
Table 107. Nishchem International Pvt. Ltd Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 108. Nishchem International Pvt. Ltd Main Business and Markets Served
Table 109. Nishchem International Pvt. Ltd Recent Developments/Updates
Table 110. Nexchem Pharmaceutical Co, ltd Glimepiride API Company Information
Table 111. Nexchem Pharmaceutical Co, ltd Glimepiride API Specification and Application
Table 112. Nexchem Pharmaceutical Co, ltd Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 113. Nexchem Pharmaceutical Co, ltd Main Business and Markets Served
Table 114. Nexchem Pharmaceutical Co, ltd Recent Developments/Updates
Table 115. Maps Laboratories Private Limited Glimepiride API Company Information
Table 116. Maps Laboratories Private Limited Glimepiride API Specification and Application
Table 117. Maps Laboratories Private Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 118. Maps Laboratories Private Limited Main Business and Markets Served
Table 119. Maps Laboratories Private Limited Recent Developments/Updates
Table 120. CAD Middle East Pharmaceutical Glimepiride API Company Information
Table 121. CAD Middle East Pharmaceutical Glimepiride API Specification and Application
Table 122. CAD Middle East Pharmaceutical Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 123. CAD Middle East Pharmaceutical Main Business and Markets Served
Table 124. CAD Middle East Pharmaceutical Recent Developments/Updates
Table 125. Hanways Chempharm Co., Limited Glimepiride API Company Information
Table 126. Hanways Chempharm Co., Limited Glimepiride API Specification and Application
Table 127. Hanways Chempharm Co., Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 128. Hanways Chempharm Co., Limited Main Business and Markets Served
Table 129. Hanways Chempharm Co., Limited Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Glimepiride API Distributors List
Table 133. Glimepiride API Customers List
Table 134. Glimepiride API Market Trends
Table 135. Glimepiride API Market Drivers
Table 136. Glimepiride API Market Challenges
Table 137. Glimepiride API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Glimepiride API
Figure 2. Global Glimepiride API Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Glimepiride API Market Share by Type: 2025 vs 2032
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Glimepiride API Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Glimepiride API Market Share by Application: 2025 vs 2032
Figure 8. Glimepiride Tablets
Figure 9. Others
Figure 10. Global Glimepiride API Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Glimepiride API Production Value (US$ Million), 2021–2032
Figure 12. Global Glimepiride API Production Capacity (Ton), 2021–2032
Figure 13. Global Glimepiride API Production (Ton), 2021–2032
Figure 14. Global Glimepiride API Average Price (US$/Ton), 2021–2032
Figure 15. Glimepiride API Report Years Considered
Figure 16. Glimepiride API Production Share by Manufacturers in 2025
Figure 17. Global Glimepiride API Production Value Share by Manufacturers (2025)
Figure 18. Glimepiride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Top 5 and Top 10 Global Players: Market Share by Glimepiride API Revenue in 2025
Figure 20. Global Glimepiride API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Glimepiride API Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 22. Global Glimepiride API Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)
Figure 23. Global Glimepiride API Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 24. India Glimepiride API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 25. Europe Glimepiride API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 26. China Glimepiride API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 27. South Korea Glimepiride API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 28. Global Glimepiride API Consumption by Region: 2021 vs 2025 vs 2032 (Ton)
Figure 29. Global Glimepiride API Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 30. North America Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 31. North America Glimepiride API Consumption Market Share by Country (2021–2032)
Figure 32. U.S. Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 33. Canada Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 34. Europe Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 35. Europe Glimepiride API Consumption Market Share by Country (2021–2032)
Figure 36. Germany Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 37. France Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 38. U.K. Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 39. Italy Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 40. Russia Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 41. Asia Pacific Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 42. Asia Pacific Glimepiride API Consumption Market Share by Region (2021–2032)
Figure 43. China Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 44. Japan Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 45. South Korea Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 46. China Taiwan Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 47. Southeast Asia Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 48. India Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 49. Latin America, Middle East & Africa Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 50. Latin America, Middle East & Africa Glimepiride API Consumption Market Share by Country (2021–2032)
Figure 51. Mexico Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 52. Brazil Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 53. Turkey Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 54. GCC Countries Glimepiride API Consumption and Growth Rate (Ton), 2021–2032
Figure 55. Global Production Market Share of Glimepiride API by Type (2021–2032)
Figure 56. Global Production Value Market Share of Glimepiride API by Type (2021–2032)
Figure 57. Global Glimepiride API Price (US$/Ton) by Type (2021–2032)
Figure 58. Global Production Market Share of Glimepiride API by Application (2021–2032)
Figure 59. Global Production Value Market Share of Glimepiride API by Application (2021–2032)
Figure 60. Global Glimepiride API Price (US$/Ton) by Application (2021–2032)
Figure 61. Glimepiride API Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Glimepiride API market?
The top companies in the global Glimepiride API market are Dr. Reddy’s Laboratories Ltd.、SANOFI Active Ingredient Solutions、Dishman Carbogen Amcis.
Related Reports
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 162
USD 4900.00
(Single User License)
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Glimepiride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 116
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 102
USD 2900.00
(Single User License)
Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-04-15
Pages: 114
USD 4900.00
(Single User License)
Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-02-23
Pages: 127
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2024
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-01-10
Pages: 103
USD 2900.00
(Single User License)
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
USD 3950.00 (Single User License)Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 162
USD 4900.00 (Single User License)Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Glimepiride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 116
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 102
USD 2900.00 (Single User License)Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-04-15
Pages: 114
USD 4900.00 (Single User License)Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-02-23
Pages: 127
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2024
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-01-10
Pages: 103
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now